Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2268-2270

  Zhang, Xun ^a   Watson, David I ^b   Jamieson, Glyn G ^c  

^a TIANJIN CHEST HOSPITAL   (China)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Adenocarcinoma; Esophageal carcinoma; Metastasis

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INVASION; CANCER SURVIVAL; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION FUNCTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; FEMALE; FISHER EXACT TEST; FOLLOW UP; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 38349156086     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00022     Document Type: Article

References (16)

1. Walther C, Zilling T, Perfekt R, Moller T. Strongly increasing incidence of adenocarcinoma of the esophagus and gastric cardia. Lakartidningen 2004; 101: 180-183.
2. Dahlberg PS, Ferrin LF, Grindle SM, Nelson CM, Hoang CD, Jacobson B. Gene expression profiles in esophageal adenocarcinoma. ANN thorac Surg 2004; 77: 1008-1015.
3. Kubo A, Corley DA. Marked regional variation in adenocarcinoma of the esophagus and the gastric cardia in the United States. Cancer 2002; 95: 2096-2102.
4. Younes M, Henson DE, Ertan A, Miller C. Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol 2002; 37: 1359-1365.
5. Dinjens WN. Genetic alteration in Barrett's oesophagus and esophageal adenocarcinoma. Minerva Chir 2002; 57: 733-752.
6. Zhang X, Watson DI, Lally C, Bessell JR. Endoscopic ultrasound for preoperative staging of esophageal carcinoma. Surg Endosc 2005; 19: 1618-1621.
7. Zhang X, Watson DI, Jamieson GG, Lally C, Bessell JR, Devitt PG. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. ANZ J Surg 2005; 75: 513-519.
8. Zhang X, Watson DI, Lally C, Bessell JR, Devitt PG. Neoadjuvant chemoradiotherapy for esophageal carcinoma. Dis Esoph 2005; 18: 1.
9. Guillem P, Fabre S, Mariette C, Triboulet JP. Surgery after induction chemoradiotherapy for oesophageal cancer. Eur J Surg Oncol 2003; 29: 158-165.
10. Clark MT, Peters JH, Ireland AP, Ehsan A, Hagen JA, Kivabu MT, et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994; 58: 646-654.
11. Korst RJ, Rusch VW, Venkatraman E, Bains MS, Burt ME, Downey RJ, et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 1998; 115: 660-669.
12. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR. Curative resection for esophageal adenocarcinoma: analysig of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-530.
13. Jeffrey AH, Steven RD, Jeffrey HP. Curative resection for esophageal adenocarcinoma analysis of 100 en bloc esophagectomies. Ann Surg 2001; 234: 520-531.
14. In: Sobin L, Wittekind C. TNM classification of maliganant tumours. 5th ed. New York: Wiley-Liss; 1997.
15. Ellis FH Jr, Heatley GJ, Krasna MJ, Williamson WA, Balogh K. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. J Thorac Cardiovasc Surg 1997; 113: 836-846.
16. Zhang X. The present and developing trend of TNM stage system of the esophageal carcinoma. Chin J Oncol (Chin) 2004; 26: 641-644.